Background: Bacterial infections (BI) are more prevalent in liver cirrhosis (LC), high among hospitalized patients. The aim of the study was to explore epidemiological pattern of BI in hospitalized patients with LC with identification of the causative agents. Objective of the study was evaluation of therapeutic/empirical approaches for infections.Methods: Inputs from the body fluid analysis and culture reports were recorded. Child Pugh score (CPS) was used to assess the severity of liver disease. Antibiotic treatment strategy was analysed, prescribed antibiotics were checked for contraindications using Lexicomp software.Results: Of 60 enrolled patients, four had mixed infection and 55% were culture positive. There was a male preponderance (83.3%). BI was more frequent in those aged 51-60 years (38.3%) and >60 years (35%). Higher proportion of patients (60%) belonged to class C of CPS followed by class B (31.7%). The most common causative organisms identified were E. coli (28.5%), K. pneumonia (14.2%), Enterococcus spp (11.4 %) and less common were K. oxytoca, Coagulase-negative staphylococci, Staphylococcus aureus, gram-positive cocci, gram-negative cocci, P. aeruginosa, S. hemolyticus, ß-hemolytic streptococcus spp. Majority of subjects had spontaneous bacterial peritonitis (36.7%) followed by urinary tract infection (21%), lower respiratory tract infection (18.3%), Sepsis (13.3%), cellulitis (3.3%) and acute gastroenteritis (1.7%). Cephalosporin's (61.7%), (rifaximin) (51.7%), penicillin and β lactamase inhibitors (36.7%) were the common prescribed antimicrobials.Conclusions: There is a positive association between the risk of BI and severity of liver damage.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.